Humacyte, Inc.
Company Stats
- Market Cap
- $143.8M
- as of Sep 30, 2026
- Shares Outstanding
- 277.8M
- Free Float
- 84.4%
Income Statement
- Revenue
- $2.0M
- Operating Income
- -$108.1M
- Net Income
- -$40.8M
- EBITDA
- -$102.8M
Cash Flow
- Free Cash Flow
- -$105.9M
- FCF Yield
- -73.7%
- Owner FCF Yield
- -80.4%
Balance Sheet
- Cash & Equivalents
- $50.5M
Returns & Capital
- SBC, 3Y Avg
- $7.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.0M | -$105.9M | -5197.5% |
| FY2024 | $0 | -$99.7M | — |
| FY2023 | — | -$75.6M | — |
| FY2022 | — | -$72.2M | — |
| FY2021 | — | -$81.4M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges